Global Fibromyalgia Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Publisher Name :
Date: 27-Jan-2023
No. of pages: 103

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.

According to our (Global Info Research) latest study, the global Fibromyalgia Drugs market size was valued at USD 2945.2 million in 2022 and is forecast to a readjusted size of USD 3308.4 million by 2029 with a CAGR of 1.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.

This report is a detailed and comprehensive analysis for global Fibromyalgia Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Fibromyalgia Drugs market size and forecasts, in consumption value ($ Million), 2018-2029

Global Fibromyalgia Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Fibromyalgia Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Fibromyalgia Drugs market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Fibromyalgia Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Fibromyalgia Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme and Daiichi Sankyo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Fibromyalgia Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

- Serotonin Norepinephrine Reuptake Inhibitors

- GABA Analogs

- Other

Market segment by Application

- Hospitals

- Clinics

- Other

Market segment by players, this report covers

- Pfizer

- Eli Lilly

- Actavis

- Merck Sharp and Dohme

- Daiichi Sankyo

- Innovative Med Concepts

- Meda

- Meiji Seika

- Switch Biotech

- Theravance

- Zynerba Pharmaceuticals

- Tonix Pharmaceuticals Holding Corp. (TNXP)

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

- South America (Brazil, Argentina and Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Fibromyalgia Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Fibromyalgia Drugs, with revenue, gross margin and global market share of Fibromyalgia Drugs from 2018 to 2023.

Chapter 3, the Fibromyalgia Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Fibromyalgia Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Fibromyalgia Drugs.

Chapter 13, to describe Fibromyalgia Drugs research findings and conclusion.

Global Fibromyalgia Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Fibromyalgia Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Fibromyalgia Drugs by Type
1.3.1 Overview: Global Fibromyalgia Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Fibromyalgia Drugs Consumption Value Market Share by Type in 2022
1.3.3 Serotonin Norepinephrine Reuptake Inhibitors
1.3.4 GABA Analogs
1.3.5 Other
1.4 Global Fibromyalgia Drugs Market by Application
1.4.1 Overview: Global Fibromyalgia Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Other
1.5 Global Fibromyalgia Drugs Market Size & Forecast
1.6 Global Fibromyalgia Drugs Market Size and Forecast by Region
1.6.1 Global Fibromyalgia Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Fibromyalgia Drugs Market Size by Region, (2018-2029)
1.6.3 North America Fibromyalgia Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Fibromyalgia Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Fibromyalgia Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Fibromyalgia Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Fibromyalgia Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Fibromyalgia Drugs Product and Solutions
2.1.4 Pfizer Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Fibromyalgia Drugs Product and Solutions
2.2.4 Eli Lilly Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Fibromyalgia Drugs Product and Solutions
2.3.4 Actavis Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Actavis Recent Developments and Future Plans
2.4 Merck Sharp and Dohme
2.4.1 Merck Sharp and Dohme Details
2.4.2 Merck Sharp and Dohme Major Business
2.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Product and Solutions
2.4.4 Merck Sharp and Dohme Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Sharp and Dohme Recent Developments and Future Plans
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Fibromyalgia Drugs Product and Solutions
2.5.4 Daiichi Sankyo Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Daiichi Sankyo Recent Developments and Future Plans
2.6 Innovative Med Concepts
2.6.1 Innovative Med Concepts Details
2.6.2 Innovative Med Concepts Major Business
2.6.3 Innovative Med Concepts Fibromyalgia Drugs Product and Solutions
2.6.4 Innovative Med Concepts Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Innovative Med Concepts Recent Developments and Future Plans
2.7 Meda
2.7.1 Meda Details
2.7.2 Meda Major Business
2.7.3 Meda Fibromyalgia Drugs Product and Solutions
2.7.4 Meda Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Meda Recent Developments and Future Plans
2.8 Meiji Seika
2.8.1 Meiji Seika Details
2.8.2 Meiji Seika Major Business
2.8.3 Meiji Seika Fibromyalgia Drugs Product and Solutions
2.8.4 Meiji Seika Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Meiji Seika Recent Developments and Future Plans
2.9 Switch Biotech
2.9.1 Switch Biotech Details
2.9.2 Switch Biotech Major Business
2.9.3 Switch Biotech Fibromyalgia Drugs Product and Solutions
2.9.4 Switch Biotech Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Switch Biotech Recent Developments and Future Plans
2.10 Theravance
2.10.1 Theravance Details
2.10.2 Theravance Major Business
2.10.3 Theravance Fibromyalgia Drugs Product and Solutions
2.10.4 Theravance Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Theravance Recent Developments and Future Plans
2.11 Zynerba Pharmaceuticals
2.11.1 Zynerba Pharmaceuticals Details
2.11.2 Zynerba Pharmaceuticals Major Business
2.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Product and Solutions
2.11.4 Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zynerba Pharmaceuticals Recent Developments and Future Plans
2.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
2.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Details
2.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
2.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product and Solutions
2.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fibromyalgia Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Fibromyalgia Drugs by Company Revenue
3.2.2 Top 3 Fibromyalgia Drugs Players Market Share in 2022
3.2.3 Top 6 Fibromyalgia Drugs Players Market Share in 2022
3.3 Fibromyalgia Drugs Market: Overall Company Footprint Analysis
3.3.1 Fibromyalgia Drugs Market: Region Footprint
3.3.2 Fibromyalgia Drugs Market: Company Product Type Footprint
3.3.3 Fibromyalgia Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Fibromyalgia Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Fibromyalgia Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Fibromyalgia Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Fibromyalgia Drugs Consumption Value by Type (2018-2029)
6.2 North America Fibromyalgia Drugs Consumption Value by Application (2018-2029)
6.3 North America Fibromyalgia Drugs Market Size by Country
6.3.1 North America Fibromyalgia Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Fibromyalgia Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Fibromyalgia Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Fibromyalgia Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Fibromyalgia Drugs Consumption Value by Type (2018-2029)
7.2 Europe Fibromyalgia Drugs Consumption Value by Application (2018-2029)
7.3 Europe Fibromyalgia Drugs Market Size by Country
7.3.1 Europe Fibromyalgia Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Fibromyalgia Drugs Market Size and Forecast (2018-2029)
7.3.3 France Fibromyalgia Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Fibromyalgia Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Fibromyalgia Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Fibromyalgia Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Fibromyalgia Drugs Market Size by Region
8.3.1 Asia-Pacific Fibromyalgia Drugs Consumption Value by Region (2018-2029)
8.3.2 China Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8.3.5 India Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Fibromyalgia Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Fibromyalgia Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Fibromyalgia Drugs Consumption Value by Type (2018-2029)
9.2 South America Fibromyalgia Drugs Consumption Value by Application (2018-2029)
9.3 South America Fibromyalgia Drugs Market Size by Country
9.3.1 South America Fibromyalgia Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Fibromyalgia Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Fibromyalgia Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Fibromyalgia Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Fibromyalgia Drugs Market Size by Country
10.3.1 Middle East & Africa Fibromyalgia Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Fibromyalgia Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Fibromyalgia Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Fibromyalgia Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Fibromyalgia Drugs Market Drivers
11.2 Fibromyalgia Drugs Market Restraints
11.3 Fibromyalgia Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Fibromyalgia Drugs Industry Chain
12.2 Fibromyalgia Drugs Upstream Analysis
12.3 Fibromyalgia Drugs Midstream Analysis
12.4 Fibromyalgia Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Fibromyalgia Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Fibromyalgia Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Fibromyalgia Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Fibromyalgia Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Fibromyalgia Drugs Product and Solutions
Table 8. Pfizer Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Eli Lilly Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Fibromyalgia Drugs Product and Solutions
Table 13. Eli Lilly Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eli Lilly Recent Developments and Future Plans
Table 15. Actavis Company Information, Head Office, and Major Competitors
Table 16. Actavis Major Business
Table 17. Actavis Fibromyalgia Drugs Product and Solutions
Table 18. Actavis Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Actavis Recent Developments and Future Plans
Table 20. Merck Sharp and Dohme Company Information, Head Office, and Major Competitors
Table 21. Merck Sharp and Dohme Major Business
Table 22. Merck Sharp and Dohme Fibromyalgia Drugs Product and Solutions
Table 23. Merck Sharp and Dohme Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck Sharp and Dohme Recent Developments and Future Plans
Table 25. Daiichi Sankyo Company Information, Head Office, and Major Competitors
Table 26. Daiichi Sankyo Major Business
Table 27. Daiichi Sankyo Fibromyalgia Drugs Product and Solutions
Table 28. Daiichi Sankyo Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Daiichi Sankyo Recent Developments and Future Plans
Table 30. Innovative Med Concepts Company Information, Head Office, and Major Competitors
Table 31. Innovative Med Concepts Major Business
Table 32. Innovative Med Concepts Fibromyalgia Drugs Product and Solutions
Table 33. Innovative Med Concepts Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Innovative Med Concepts Recent Developments and Future Plans
Table 35. Meda Company Information, Head Office, and Major Competitors
Table 36. Meda Major Business
Table 37. Meda Fibromyalgia Drugs Product and Solutions
Table 38. Meda Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Meda Recent Developments and Future Plans
Table 40. Meiji Seika Company Information, Head Office, and Major Competitors
Table 41. Meiji Seika Major Business
Table 42. Meiji Seika Fibromyalgia Drugs Product and Solutions
Table 43. Meiji Seika Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Meiji Seika Recent Developments and Future Plans
Table 45. Switch Biotech Company Information, Head Office, and Major Competitors
Table 46. Switch Biotech Major Business
Table 47. Switch Biotech Fibromyalgia Drugs Product and Solutions
Table 48. Switch Biotech Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Switch Biotech Recent Developments and Future Plans
Table 50. Theravance Company Information, Head Office, and Major Competitors
Table 51. Theravance Major Business
Table 52. Theravance Fibromyalgia Drugs Product and Solutions
Table 53. Theravance Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Theravance Recent Developments and Future Plans
Table 55. Zynerba Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 56. Zynerba Pharmaceuticals Major Business
Table 57. Zynerba Pharmaceuticals Fibromyalgia Drugs Product and Solutions
Table 58. Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Zynerba Pharmaceuticals Recent Developments and Future Plans
Table 60. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information, Head Office, and Major Competitors
Table 61. Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
Table 62. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product and Solutions
Table 63. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments and Future Plans
Table 65. Global Fibromyalgia Drugs Revenue (USD Million) by Players (2018-2023)
Table 66. Global Fibromyalgia Drugs Revenue Share by Players (2018-2023)
Table 67. Breakdown of Fibromyalgia Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Fibromyalgia Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Fibromyalgia Drugs Players
Table 70. Fibromyalgia Drugs Market: Company Product Type Footprint
Table 71. Fibromyalgia Drugs Market: Company Product Application Footprint
Table 72. Fibromyalgia Drugs New Market Entrants and Barriers to Market Entry
Table 73. Fibromyalgia Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Fibromyalgia Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Fibromyalgia Drugs Consumption Value Share by Type (2018-2023)
Table 76. Global Fibromyalgia Drugs Consumption Value Forecast by Type (2024-2029)
Table 77. Global Fibromyalgia Drugs Consumption Value by Application (2018-2023)
Table 78. Global Fibromyalgia Drugs Consumption Value Forecast by Application (2024-2029)
Table 79. North America Fibromyalgia Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Fibromyalgia Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Fibromyalgia Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Fibromyalgia Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Fibromyalgia Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Fibromyalgia Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Fibromyalgia Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Fibromyalgia Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Fibromyalgia Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Fibromyalgia Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Fibromyalgia Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Fibromyalgia Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Fibromyalgia Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Fibromyalgia Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Fibromyalgia Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Fibromyalgia Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Fibromyalgia Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Fibromyalgia Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Fibromyalgia Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Fibromyalgia Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Fibromyalgia Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Fibromyalgia Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Fibromyalgia Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Fibromyalgia Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Fibromyalgia Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Fibromyalgia Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Fibromyalgia Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Fibromyalgia Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Fibromyalgia Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Fibromyalgia Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Fibromyalgia Drugs Raw Material
Table 110. Key Suppliers of Fibromyalgia Drugs Raw Materials
List of Figures
Figure 1. Fibromyalgia Drugs Picture
Figure 2. Global Fibromyalgia Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Fibromyalgia Drugs Consumption Value Market Share by Type in 2022
Figure 4. Serotonin Norepinephrine Reuptake Inhibitors
Figure 5. GABA Analogs
Figure 6. Other
Figure 7. Global Fibromyalgia Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Fibromyalgia Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Other Picture
Figure 12. Global Fibromyalgia Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Fibromyalgia Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Fibromyalgia Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Fibromyalgia Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Fibromyalgia Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Fibromyalgia Drugs Revenue Share by Players in 2022
Figure 23. Fibromyalgia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Fibromyalgia Drugs Market Share in 2022
Figure 25. Global Top 6 Players Fibromyalgia Drugs Market Share in 2022
Figure 26. Global Fibromyalgia Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Fibromyalgia Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Fibromyalgia Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Fibromyalgia Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Fibromyalgia Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Fibromyalgia Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Fibromyalgia Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Fibromyalgia Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Fibromyalgia Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Fibromyalgia Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Fibromyalgia Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Fibromyalgia Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Fibromyalgia Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Fibromyalgia Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Fibromyalgia Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Fibromyalgia Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Fibromyalgia Drugs Market Drivers
Figure 65. Fibromyalgia Drugs Market Restraints
Figure 66. Fibromyalgia Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Fibromyalgia Drugs in 2022
Figure 69. Manufacturing Process Analysis of Fibromyalgia Drugs
Figure 70. Fibromyalgia Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs